These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 1496998)

  • 21. Molecular analysis of p53 and K-ras in lung carcinomas of coal miners.
    Sarkar FH; Li Y; Vallyathan V
    Int J Mol Med; 2001 Oct; 8(4):453-9. PubMed ID: 11562787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular genetics of small cell lung carcinoma.
    Wistuba II; Gazdar AF; Minna JD
    Semin Oncol; 2001 Apr; 28(2 Suppl 4):3-13. PubMed ID: 11479891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Initiators and promoters of lung cancer.
    Mulshine JL; Treston AM; Brown PH; Birrer MJ; Shaw GL
    Chest; 1993 Jan; 103(1 Suppl):4S-11S. PubMed ID: 8380133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lung cancer risk in germline p53 mutation carriers: association between an inherited cancer predisposition, cigarette smoking, and cancer risk.
    Hwang SJ; Cheng LS; Lozano G; Amos CI; Gu X; Strong LC
    Hum Genet; 2003 Aug; 113(3):238-43. PubMed ID: 12802680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mechanisms for inactivation of tumor suppressor genes].
    Ishizaki K
    Nihon Rinsho; 1995 Nov; 53(11):2660-5. PubMed ID: 8538022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A translational view of the molecular pathogenesis of lung cancer.
    Sato M; Shames DS; Gazdar AF; Minna JD
    J Thorac Oncol; 2007 Apr; 2(4):327-43. PubMed ID: 17409807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular biologic features of non-small cell lung cancer. Clinical implications.
    Rusch VW; Dmitrovsky E
    Chest Surg Clin N Am; 1995 Feb; 5(1):39-55. PubMed ID: 7743147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p53 gene aberrations in non-small-cell lung carcinomas from a smoking population.
    Liloglou T; Ross H; Prime W; Donnelly RJ; Spandidos DA; Gosney JR; Field JK
    Br J Cancer; 1997; 75(8):1119-24. PubMed ID: 9099958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [2000 Standards, Options and Recommendations for prognostic value of oncogenes and tumor suppressor genes in non small cell lung cancer].
    Bréchot JM; Molina T; Theobald S; Depierre A; Lagrange JL; Astoul P; Baldeyrou P; Bardet E; Bazelly B; Breton JL; Douillard JY; Grivaux M; Jacoulet P; Khalil A; Lemarié E; Martinet Y; Massard G; Milleron B; Moro-Sibilot D; Paesmans M; Pujol JL; Quoix AE; Ranfaing E; Rivière A; Sancho-Garnier H; Souquet PJ; Spaeth D; Stcebner-Delbarre A;
    Bull Cancer; 2002 Oct; 89(10):857-67. PubMed ID: 12441277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gender is a risk factor for lung cancer.
    Gasperino J
    Med Hypotheses; 2011 Mar; 76(3):328-31. PubMed ID: 21106301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk for K-ras gene mutations in smoking-induced lung cancer is associated with cytochrome P4501A1 and glutathione S-transferase micro1 polymorphisms.
    Noda N; Matsuzoe D; Konno T; Kawahara K; Yamashita Y; Shirakusa T
    Oncol Rep; 2004 Oct; 12(4):773-9. PubMed ID: 15375499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patterns of EGFR, HER2, TP53, and KRAS mutations of p14arf expression in non-small cell lung cancers in relation to smoking history.
    Mounawar M; Mukeria A; Le Calvez F; Hung RJ; Renard H; Cortot A; Bollart C; Zaridze D; Brennan P; Boffetta P; Brambilla E; Hainaut P
    Cancer Res; 2007 Jun; 67(12):5667-72. PubMed ID: 17575133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Molecular biology of lung cancer].
    Akita H
    Nihon Kokyuki Gakkai Zasshi; 2004 May; 42(5):378-86. PubMed ID: 15168453
    [No Abstract]   [Full Text] [Related]  

  • 34. Tobacco and cancer: epidemiology and the laboratory.
    Vineis P; Caporaso N
    Environ Health Perspect; 1995 Feb; 103(2):156-60. PubMed ID: 7737063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tobacco smoke carcinogens and lung cancer.
    Hecht SS
    J Natl Cancer Inst; 1999 Jul; 91(14):1194-210. PubMed ID: 10413421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Tumor suppressor genes].
    Kohno T; Yokota J
    Gan To Kagaku Ryoho; 1993 Jul; 20(9):1265-73. PubMed ID: 8392829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Smoking and cancer-related gene expression in bronchial epithelium and non-small-cell lung cancers.
    Woenckhaus M; Klein-Hitpass L; Grepmeier U; Merk J; Pfeifer M; Wild P; Bettstetter M; Wuensch P; Blaszyk H; Hartmann A; Hofstaedter F; Dietmaier W
    J Pathol; 2006 Oct; 210(2):192-204. PubMed ID: 16915569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carcinogen exposure, p53 alteration, and K-ras mutation in synchronous multiple primary lung carcinoma.
    Wang X; Christiani DC; Mark EJ; Nelson H; Wiencke JK; Gunn L; Wain JC; Kelsey KT
    Cancer; 1999 Apr; 85(8):1734-9. PubMed ID: 10223567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutations in the p53 gene in lung cancer are associated with cigarette smoking and asbestos exposure.
    Wang X; Christiani DC; Wiencke JK; Fischbein M; Xu X; Cheng TJ; Mark E; Wain JC; Kelsey KT
    Cancer Epidemiol Biomarkers Prev; 1995; 4(5):543-8. PubMed ID: 7549812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Molecular genetics of human pancreatic cancer].
    Villanueva A; Capellá G; Mangues R; Farré A; Lluís F
    Gastroenterol Hepatol; 1999 Nov; 22(9):444-50. PubMed ID: 10638042
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.